RDs play a central role in this process, providing MNT that evolves based on the patients clinical response, dietary intake, muscle mass, and tolerance to medication.50,51 Before initiating GLP-1 therapy, clinicians should assess baseline diet, medical conditions, disordered eating patterns, and social determinants of health to identify barriers and tailor care.19 Ongoing monitoring should include changes in weight, muscle strength, and nutrient intake, using flexible care delivery models such as telehealth, group visits, or Food is Medicine programs to improve access and equity to nutrient dense foods.19 MNT Recommendations To support long-term success, lifestyle interventions must be structured and ongoing
What to Expect During Semaglutide Treatment Semaglutide treatment starts with a low dose, gradually increasing as you adapt to the medication
GHK-Cu (Copper Tripeptide-1) What It Is: A naturally occurring copper-peptide complex with profound skin regeneration and tissue remodeling properties
Both medications commonly cause gastrointestinal side effects like nausea, especially when starting treatment
L-Carnitine is required for mitochondrial -oxidation of long-chain fatty acids for energy production (1)
For people with kidney disease and other health issues that arise from chronic inflammation, using supplemental glutathione can be powerful
